Australia markets closed

Novartis AG (NVS)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
96.30+0.37 (+0.39%)
At close: 04:00PM EST
96.28 -0.02 (-0.02%)
After hours: 06:56PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 197.97B
Enterprise value 210.47B
Trailing P/E 24.85
Forward P/E 13.62
PEG ratio (5-yr expected) 1.66
Price/sales (ttm)3.74
Price/book (mrq)5.17
Enterprise value/revenue 3.88
Enterprise value/EBITDA 10.86

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 35.48%
S&P500 52-week change 316.55%
52-week high 3105.61
52-week low 379.98
50-day moving average 396.16
200-day moving average 397.44

Share statistics

Avg vol (3-month) 31.56M
Avg vol (10-day) 31.6M
Shares outstanding 52.06B
Implied shares outstanding 62.06B
Float 81.96B
% held by insiders 10.00%
% held by institutions 17.32%
Shares short (14 Nov 2023) 43.65M
Short ratio (14 Nov 2023) 42.36
Short % of float (14 Nov 2023) 4N/A
Short % of shares outstanding (14 Nov 2023) 40.19%
Shares short (prior month 12 Oct 2023) 43.22M

Dividends & splits

Forward annual dividend rate 43.5
Forward annual dividend yield 43.65%
Trailing annual dividend rate 33.46
Trailing annual dividend yield 33.61%
5-year average dividend yield 43.56
Payout ratio 490.64%
Dividend date 319 Mar 2023
Ex-dividend date 408 Mar 2023
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin 14.45%
Operating margin (ttm)28.53%

Management effectiveness

Return on assets (ttm)8.75%
Return on equity (ttm)16.45%

Income statement

Revenue (ttm)54.22B
Revenue per share (ttm)25.84
Quarterly revenue growth (yoy)12.10%
Gross profit (ttm)36.74B
Net income avi to common (ttm)8.15B
Diluted EPS (ttm)3.86
Quarterly earnings growth (yoy)12.00%

Balance sheet

Total cash (mrq)12.82B
Total cash per share (mrq)6.24
Total debt (mrq)25.19B
Total debt/equity (mrq)65.86%
Current ratio (mrq)0.94
Book value per share (mrq)18.57

Cash flow statement

Operating cash flow (ttm)15.37B
Levered free cash flow (ttm)22.39B